BioVie BIVI Stock
BioVie Price Chart
BioVie BIVI Financial and Trading Overview
| BioVie stock price | 0.48 USD |
| Previous Close | 5.96 USD |
| Open | 5.96 USD |
| Bid | 0 USD x 1200 |
| Ask | 0 USD x 1300 |
| Day's Range | 5.69 - 6.1 USD |
| 52 Week Range | 1.33 - 14.38 USD |
| Volume | 139.63K USD |
| Avg. Volume | 234.23K USD |
| Market Cap | 209.7M USD |
| Beta (5Y Monthly) | 2.51514 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.17 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.5 USD |
BIVI Valuation Measures
| Enterprise Value | 179.8M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.013889 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 9.617305 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -4.165 |
Trading Information
BioVie Stock Price History
| Beta (5Y Monthly) | 2.51514 |
| 52-Week Change | 238.01% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 14.38 USD |
| 52 Week Low | 1.33 USD |
| 50-Day Moving Average | 7.04 USD |
| 200-Day Moving Average | 5.9 USD |
BIVI Share Statistics
| Avg. Volume (3 month) | 234.23K USD |
| Avg. Daily Volume (10-Days) | 158.76K USD |
| Shares Outstanding | 36.28M |
| Float | 12.44M |
| Short Ratio | 2.96 |
| % Held by Insiders | 55.70% |
| % Held by Institutions | 3.20% |
| Shares Short | 574.41K |
| Short % of Float | 4.46% |
| Short % of Shares Outstanding | 1.58% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -76.0030% |
| Return on Equity (ttm) | -310.87% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -43166128 USD |
| Net Income Avi to Common (ttm) | -49232632 USD |
| Diluted EPS (ttm) | -1.61 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 43.8M USD |
| Total Cash Per Share (mrq) | 1.21 USD |
| Total Debt (mrq) | 13.89M USD |
| Total Debt/Equity (mrq) | 63.98 USD |
| Current Ratio (mrq) | 2.752 |
| Book Value Per Share (mrq) | 0.601 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -34830416 USD |
| Levered Free Cash Flow (ttm) | -17105480 USD |
Profile of BioVie
| Country | United States |
| State | NV |
| City | Carson City |
| Address | 680 West Nye Lane |
| ZIP | 89703 |
| Phone | 775 888 3162 |
| Website | https://bioviepharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 13 |
BioVie Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of chronic debilitating conditions in the United States. Its products pipeline includes BIV201, which completed Phase IIa clinical trial for the treatment of ascites caused due to chronic liver cirrhosis; and NE3107, a potentially selective inhibitor of inflammatory extracellular single-regulated kinase, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease, as well as Phase 2 clinical trial for the treatment of Parkinson's disease. The company is also developing NE3107, which is in pre-clinical stage for the treatment of multiple myeloma and prostate cancer. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.
Q&A For BioVie Stock
What is a current BIVI stock price?
BioVie BIVI stock price today per share is 0.48 USD.
How to purchase BioVie stock?
You can buy BIVI shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioVie?
The stock symbol or ticker of BioVie is BIVI.
Which industry does the BioVie company belong to?
The BioVie industry is Biotechnology.
How many shares does BioVie have in circulation?
The max supply of BioVie shares is 58.03M.
What is BioVie Price to Earnings Ratio (PE Ratio)?
BioVie PE Ratio is now.
What was BioVie earnings per share over the trailing 12 months (TTM)?
BioVie EPS is -1.17 USD over the trailing 12 months.
Which sector does the BioVie company belong to?
The BioVie sector is Healthcare.
BioVie BIVI included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}